For Patients

Primary Immune Deficiency Diseases (PI)

Primary immunodeficiency diseases (PI) are a group of more than 350 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly. While not contagious, these diseases are caused by hereditary or genetic defects, and, although some disorders present at birth or in early childhood, the disorders can affect anyone, regardless of age or gender. Some affect a single part of the immune system; others may affect one or more components of the system. While the diseases may differ, they all share one common feature; each results from a defect in one of the functions of the body’s normal immune system.

For people living with PI, infections may not go away or can come back often, even with the use of medications. Infections may be common, severe, long-lasting, hard to cure and may become life threatening.

Treatments

  •  Antibiotics (long-term)
  • Bone Marrow Transplants
  • Gene Therapy
  •  Immune Globulin Therapy

More Information

please visit the Immune Deficiency Foundation at https://primaryimmune.org/

please visit the Jeffrey Modell Foundation at http://www.info4pi.org/

Products We Offer

Immune Globulin Therapy

Corticosteroids

Contact CSI Pharmacy for more information on Corticosteroids.

Immune Globulin Therapy

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, IVIG is administered intravenously and is used primarily to treat three categories of illnesses: primary immune deficiency diseases, autoimmune diseases and certain neurological disorders.

  • Bivigam
    ADMA Biologics
  • Gammagard S/D
    Takeda
  • Gammagard Liquid
    Takeda
  • Gammaked
    Kedrion
  • Gamunex-C
    Grifols
  • Octagam 5%
    Octapharma
  • Octagam 10%
    Octapharma
  • Privigen
    CSL Behring
  • Panzyga
    Pfizer

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, SCIG is administered subcutaneously and is approved to treat primary immune deficiencies and chronic inflammatory demyelinating polyneuropathy. It is also in clinical trials for autoimmune diseases.

  • Cutaquig
    Takeda
  • Gammagard Liquid
    Takeda
  • Gammaked
    Kedrion
  • Gamunex-C
    Grifols
  • Hizentra
    CSL Behring
  • HyQvia
    Takeda
  • Xembify
    Grifols